Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
PC 360
Article
Property Casualty 360°: The role of empathy in workers' comp
Most of us deal with sick and injured workers on a daily basis. At some point, daily tasks and deadlines take over and empathy takes a backseat.
Business Insurance
In the News
Patient transport helps build bridge back to work
Discover how patient transport services are accelerating return-to-work journeys—learn how your organization can bridge recovery and productivity today.
Workers' Comp
News Release
Genex First in Work Comp Industry to Develop Comprehensive Transportation Guidelines
April 14, 2015—Wayne, Pa.—Genex Services, the nation's largest provider of workers' compensation clinical services, announced toda
Workers' Comp
News Release
Genex Earns URAC Reaccreditation for WCUM and CM
URAC evaluation validates company's high performance standards
PDF
In the News
Early Case Management Speeds RTW, Report Says
Early case management doubles return-to-work success rates, says Genex report. Identifying red flags early helps reduce claim costs, delays, and litigation.
Workers' Comp
News Release